藏成药“十三味榜嘎散”显微鉴别研究  

Study on microscopic identification of Tibetan patent medicine "Shisanwei Bangga San"

作　　者：连艳[1] 齐景梁 黎跃成 周娟 高必兴 LIAN Yan;QI Jing-liang;LI Yue-cheng;ZHOU Juan;GAO Bi-xing(School of Pharmacy,Chengdu University of Traditional Chinese Medicine,State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China,The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicine,Chengdu 61l137,Sichuan;Sichuan Institute for Drug Control(Sichuan Testing enter for Medical Devices)/Key Laboratory of Quality Evaluation of Chinese Patent Medicines,Chengdu 611731,Sichuan)

机构地区：[1]成都中医药大学药学院西南特色中药资源国家重点实验室中药材标准化重点实验室,四川成都611137 [2]四川省药品检验研究院/国家药品监督管理局中成药质量评价重点实验室,四川成都611731

出　　处：《中药与临床》2022年第5期35-38,共4页Pharmacy and Clinics of Chinese Materia Medica

基　　金：四川省自然科学基金(2022NSFSC1548)。

摘　　要：目的:探讨2020年版《中国药典》一部成方制剂项下十三味榜嘎散标准中显微鉴别项的相关问题,为下一版《中国药典》的修订提出参考。方法:对十三味榜嘎散及组成药材进行显微鉴别研究。结果:部分药材显微特征存在交叉,或与规定不符,或检验困难。结论:建议使用其它显微特征或鉴别方法对十三味榜嘎散的投料药材进行规范。Objective: To explore the related problems of the microscopic identification items in the standard of Shisanwei Bangga San under the prescription preparation in the first part of Chinese Pharmacopoeia 2020, and provide references for the revision of the next edition of Chinese Pharmacopoeia. Method: The microscopic identification of Shisanwei Bangga San and its components was carried out. Result: The microscopic characteristics of some herbs were overlapping, or inconsistent with the regulations, or difficult to test. Conclusion: It is suggested that other microscopic characteristics or identification methods should be used to standardize the raw materials of Shisanwei Bangga San.

关 键 词：2020年版《中国药典》 十三味榜嘎散 显微鉴别 

分 类 号：R283[医药卫生—中药学]